| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 22,443 | $337,543 | $15.04 | 03 Feb 2025 | Direct |
| ROCKET PHARMACEUTICALS, INC. | Director | Common Stock | 30,000 | $235,800 | $7.86 | 18 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS, INC. | 18 Jun 2025 | 1 | $0 | 4 | Director | 18 Jul 2025, 16:05 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 03 Feb 2025 | 2 | $0 | 4 | Director | 05 Feb 2025, 19:47 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 27 Jan 2025 | 0 | $0 | 3 | Director | 05 Feb 2025, 19:43 |